Q2 2024 |
4 |
$179M |
+$53.1M |
$0 |
+$53.1M |
BHVN, CYTK, BCRX, VIRX
|
13F-HR |
8/13/2024, 12:25 PM |
Q1 2024 |
3 |
$180M |
$0 |
$0 |
|
BHVN, BCRX, VIRX
|
13F-HR |
5/8/2024, 05:21 PM |
Q4 2023 |
3 |
$149M |
$0 |
$0 |
|
BHVN, BCRX, VIRX
|
13F-HR |
2/13/2024, 05:29 PM |
Q3 2023 |
3 |
$104M |
$0 |
$0 |
|
BHVN, BCRX, VIRX
|
13F-HR |
11/13/2023, 03:07 PM |
Q2 2023 |
3 |
$97.3M |
$0 |
$0 |
|
BHVN, BCRX, VIRX
|
13F-HR |
8/11/2023, 12:04 PM |
Q1 2023 |
3 |
$72.2M |
$0 |
$0 |
|
BHVN, BCRX, VIRX
|
13F-HR |
5/15/2023, 01:13 PM |
Q4 2022 |
3 |
$84.9M |
+$40.8M |
-$168M |
-$127M |
BCRX, BHVN, VIRX
|
13F-HR |
2/14/2023, 01:04 PM |
Q3 2022 |
3 |
$216M |
$0 |
-$46.8M |
-$46.8M |
BHVNXXXX, BCRX, VIRX
|
13F-HR |
11/14/2022, 02:41 PM |
Q2 2022 |
4 |
$249M |
$0 |
$0 |
|
BHVNXXXX, EPZM, BCRX, VIRX
|
13F-HR |
8/10/2022, 03:12 PM |
Q1 2022 |
3 |
$194M |
$0 |
$0 |
|
BHVNXXXX, BCRX, VIRX
|
13F-HR |
5/11/2022, 04:41 PM |
Q4 2021 |
4 |
$219M |
+$43M |
$0 |
+$43M |
BHVNXXXX, BCRX, EPZM, VIRX
|
13F-HR |
2/14/2022, 12:50 PM |
Q3 2021 |
3 |
$201M |
$0 |
$0 |
|
BHVNXXXX, EPZM, VIRX
|
13F-HR |
11/15/2021, 04:20 PM |
Q2 2021 |
3 |
$184M |
$0 |
-$117M |
-$117M |
BHVNXXXX, EPZM, VIRX
|
13F-HR |
8/12/2021, 01:32 PM |
Q1 2021 |
4 |
$245M |
+$34K |
$0 |
+$34K |
BHVNXXXX, EPZM, CYTK, VIRX
|
13F-HR |
5/17/2021, 12:59 PM |
Q4 2020 |
3 |
$299M |
$0 |
-$372M |
-$372M |
BHVNXXXX, EPZM, CYTK
|
13F-HR |
2/12/2021, 07:43 PM |
Q3 2020 |
4 |
$637M |
$0 |
$0 |
|
IMMU, BHVNXXXX, EPZM, CYTK
|
13F-HR |
11/12/2020, 12:32 PM |
Q2 2020 |
5 |
$477M |
$0 |
$0 |
|
IMMU, BHVNXXXX, EPZM, CYTK, SNSS
|
13F-HR |
8/14/2020, 10:23 AM |
Q1 2020 |
5 |
$283M |
+$38.8M |
$0 |
+$38.8M |
EPZM, BHVNXXXX, IMMU, CYTK, SNSS
|
13F-HR |
5/15/2020, 11:23 AM |
Q4 2019 |
5 |
$381M |
+$164M |
$0 |
+$164M |
EPZM, BHVNXXXX, IMMU, CYTK, SNSS
|
13F-HR |
2/13/2020, 07:14 PM |
Q3 2019 |
4 |
$156M |
$0 |
$0 |
|
BHVNXXXX, IMMU, CYTK, SNSS
|
13F-HR |
11/14/2019, 03:22 PM |
Q2 2019 |
4 |
$163M |
$0 |
$0 |
|
BHVNXXXX, IMMU, CYTK, SNSS
|
13F-HR |
8/7/2019, 12:00 PM |
Q1 2019 |
4 |
$200M |
$0 |
$0 |
|
BHVNXXXX, IMMU, CYTK, SNSS
|
13F-HR |
5/15/2019, 11:31 AM |
Q4 2018 |
4 |
$146M |
$0 |
$0 |
|
BHVN, IMMU, CYTK, SNSS
|
13F-HR |
2/14/2019, 10:33 AM |